Idexx Laboratories SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KNov. 2, 2026, 6:30 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedIDEXX Laboratories beats Q3 2026 estimates with EPS of $4.01 and revenue of $1.21 billion; raises 2026 revenue and EPS guidance
8-KAug. 4, 2026, 6:32 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits